Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that it will present an invited...
-
Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.
-
ROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S....
-
The global market for neuroprotective agents was valued at $41.2 billion in 2024 and is expected to reach $60.9 billion by the end of 2030.
-
SHENZHEN, China, March 12, 2026 (GLOBE NEWSWIRE) -- On March 10, 2026, the team led by Dr. An Chiying at Shenzhen Hengsheng Hospital, affiliated with Shanghai Fosun Health, publicly announced that...
-
Cell Freezing Media Market is growing due to rising stem cell research, biopharmaceutical development, and advancements in cryopreservation technology.
-
Toronto, Ontario, March 09, 2026 (GLOBE NEWSWIRE) -- The Entente Foundation (formerly RTOERO Foundation) has announced Dr. Jennifer Watt as the new Entente Education Canada Chair in Geriatric...
-
ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis.
-
SPADA launches to unite Southern California’s aerospace & defense ecosystem, debuting March 11 with OJ Sanchez and Rep. Whitesides
-
Etienna Bio, Inc., announces the formation of its Scientific Advisory Board with the appointment of two internationally recognized leaders in cell biology